Healius Limited (Healius) has announced that it has entered into an agreement to acquire Agilex Biolabs, Australia’s largest and most technologically advanced bioanalytical and toxicology laboratory. This is the ideal next step for Agilex Biolabs to progress its global vision.  With a shared philosophy to improve health outcomes, this acquisition will strengthen Agilex Biolabs, to position its offering on a larger scale. 

“The acquisition of Agilex is an exciting opportunity for Healius. Agilex has a talented scientific team with state of the art laboratories and culturally compliments Healius. It’s a logical entry point for Healius into the attractive global bioanalytical laboratory services market, and one in which Australia and Agilex, in particular, is well-placed to service.”

Healius Managing director and CEO – Dr Malcolm Parmenter

Healius is one of Australia’s leading healthcare companies providing high quality, accessible and cost-efficient healthcare services through its Pathology, Imaging and Day Hospital businesses. With a unique footprint of more than 2,000 locations and 11,000+ employees, Healius provides speciality diagnostic services to consumers and their referring practitioners, as well as enabling a range of independent healthcare professionals to deliver patient care in partnership with Healius’ nurses and support teams.

“The acquisition by Healius is the ideal next step for Agilex Biolabs to progress our vision.  With a shared philosophy to improve health outcomes and a shared strategic vision for the company, we look forward to progressing on our plans for growth of the Agilex Biolabs business.” 

Agilex Biolabs CEO – Jason Valentine

Read the full press release here